Navigation Links
Measles Risk in Transplant Patients

People with a compromised immune system who have undergone organ transplantation could be at a high risk of measles if they don’t receive the measles, mumps and rubella vaccine in a timely manner.//

Completion of MMR vaccination in southeast London is among the lowest in the United Kingdom. Just over 60 percent of children aged 2 years received a first dose of the vaccine by March 2003. (Data shows there were 66 cases of measles reported in the second quarter of the year.) In a letter in this week’s issue of The Lancet, researchers describe how two children with kidney transplants developed complications from measles. Both children received a single dose of the MMR vaccine before transplantation, but since they were about 2 years old at the time, they were unable to have a preschool booster dose. The first dose of the vaccine is recommended at about 13 months old. The booster dose is then given between 3 and 5 years old.

Authors of the letter write, "The reappearance of measles in the community poses a severe threat to vulnerable immunocompromised individuals, including recipients of transplants. Without a substantial increase in the uptake of MMR vaccination, difficult challenges lie ahead. Measles is a notoriously infectious disease and will spread easily among those who are non-immune."

Researchers also say the two children in their report did not have typical presentations of measles and they caution researchers to be aware of this. They write, "Immunocompromised individuals may manifest only a non-specific illness without rash, which makes rapid diagnosis difficult and may delay measures to prevent further spread"
'"/>




Page: 1

Related medicine news :

1. Acute Measles Supresses HIV Replication
2. Measles Suppresses AIDS Virus
3. Drop in Worldwide Measles deaths by 40%
4. Measles Break Out In Relief Camps
5. Measles Vaccination Drive Intensified In Quake-Hit Pakistan
6. Measles Breaks Out In Kashmir
7. Measles Outbreak In Bihar Creates Panic
8. Death Due To Measles Plummet By About 50% Following WHO Campaign
9. Measles Resurges Due To Drop In Immunization With MMR
10. Staff Nurses Contract Measles from the Patient
11. Generous Donation by US Helps to Curb the Outbreak of Measles in Fiji
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... AWARE: A Week of Addiction and Recovery Education, from April 24 to April ... preventing substance use disorders. , The mission of AWARE is to instill ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... Worcestershire, UK (PRWEB) , ... April 21, 2017 ... ... Award for Enterprise in the category of International Trade, the UK’s most prestigious ... in international trade, which represents 95% of total revenues and has grown by ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
Breaking Medicine Technology: